Familial visceral amyloidosis, Ostertag type: genes and variants
Explore variant evidence for Familial visceral amyloidosis, Ostertag type across 2 analyzed proteins (FGA, APOA1). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 62 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial visceral amyloidosis, Ostertag type
FGA: Fibrinogen alpha chain
It contributes the alpha chains of fibrinogen, which thrombin converts into fibrin to form the structural mesh of blood clots. Pathogenic variants can cause afibrinogenemia, hypofibrinogenemia, dysfibrinogenemia, thrombosis, or certain hereditary amyloidoses.
2 ClinVar pathogenic / likely pathogenic and 61 uncertain variants in FGA have source records linked to Familial visceral amyloidosis, Ostertag type. Association strength is not clinical gene validity.
APOA1: Apolipoprotein A-I
It is the principal protein scaffold of HDL and activates LCAT, supporting cholesterol efflux from peripheral tissues and reverse cholesterol transport. Pathogenic variants can cause very low HDL cholesterol, familial amyloidosis in some alleles, or altered cardiovascular risk.
0 ClinVar pathogenic / likely pathogenic and 8 uncertain variants in APOA1 have source records linked to Familial visceral amyloidosis, Ostertag type. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Familial visceral amyloidosis, Ostertag type
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| FGA R573C | 573 | Coiled coil | Pathogenic / likely pathogenic (★★) |
| FGA E545V | 545 | Coiled coil | Pathogenic / likely pathogenic (★★) |
Diseases related to Familial visceral amyloidosis, Ostertag type
- Hypertrophic cardiomyopathy, also linked to FGA
- Noonan syndrome, also linked to FGA
- Costello syndrome, also linked to FGA
- Familial dysfibrinogenemia, also linked to FGA
- Afibrinogenemia, also linked to FGA
- Deep venous thrombosis, also linked to FGA
- Hypoalphalipoproteinemia, primary, also linked to APOA1
- Familial amyloid polyneuropathy, Iowa type, also linked to APOA1
- Hypoalphalipoproteinemia, primary, 2, intermediate, also linked to APOA1
Frequently asked questions
Which genes have records linked to Familial visceral amyloidosis, Ostertag type?
This view contains 2 analyzed proteins: FGA, APOA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 62 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 74 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center